ArticlePloS one2014
Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization.
Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed, 4 syntheses or guidelines pooled it, 144 citations in OpenAlex.
- Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis.Frontiers in public health · 2022Pooled it
- Quality standards for safe medication in nursing homes: development through a multistep approach including a Delphi consensus study.BMJ open · 2021Guideline
- Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria.European journal of clinical pharmacology · 2018Pooled it
- Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.European journal of clinical pharmacology · 2015Pooled it
- The effects of a pharmacist-led medication review in a nursing home: A randomized controlled trial.Medicine · 2021Trial
- Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial.BMC geriatrics · 2020Trial
- Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy--a prospective randomised controlled trial.BMC health services research · 2016Trial
- Trial
- Potentially inappropriate prescribing in Iranian elderly population: a nationwide claims-based analysis.BMJ open · 2026Observational
- Polypharmacy, drug-drug interactions, and potentially inappropriate medications among older adults: a cross-sectional study in Northeast Ethiopia.Frontiers in public health · 2025Article
- Factors associated with psychotropic drugs use in older adults hospitalized in clinical and surgical wards of a university hospital.Dementia & neuropsychologia · 2025Article
- Article
- Potentially Inappropriate Medication Use in Primary Care in Switzerland.JAMA network open · 2024Article
- Use of potentially inappropriate medication for elderly patients in tertiary care hospital of Riyadh, Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024Article
- Potentially Inappropriate Medications in Older Adults-Prevalence, Trends and Associated Factors: A Cross-Sectional Study in Saudi Arabia.Healthcare (Basel, Switzerland) · 2023Article
- Global Mapping of Potentially Inappropriate Prescribing for Older Adults in Community Settings: An Umbrella Review.Korean journal of family medicine · 2023Article
- Gender Differences in Potentially Inappropriate Medication Use among Older Adults.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Developing a Warning Model of Potentially Inappropriate Medications in Older Chinese Outpatients in Tertiary Hospitals: A Machine-Learning Study.Journal of clinical medicine · 2023Article
- Potentially Inappropriate Medication Dispensing in Outpatients: Comparison of Different Measurement Approaches.Risk management and healthcare policy · 2023Article
- Using PIM-Taiwan, PRISCUS, and Beers criteria to assess potentially inappropriate medication use among older adults with 90-day rehospitalization: a population-based study in Taiwan.Frontiers in pharmacology · 2023Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the prevalence and determinants of potentially inappropriate medication (PIM) use and association with hospitalizations in an elderly managed care population in Switzerland.
methodsUsing health care claims data of four health insurers for a sample of managed care patients 65 years of age and older to compare persons on PIM with persons not on PIM. Beers' 2012 and PRISCUS criteria were used to determine the potential inappropriateness of prescribed medications. The sample included 16'490 elderly patients on PIM and 33'178 patients not on PIM in the time period of January 1, 2008 through December 31, 2012. Prevalence estimates are standardized to the population of Switzerland. Associations between PIM and hospitalizations were examined by multivariate Cox regression analyses controlling for possible confounding variables.
resultsThe estimated prevalence of PIM use in our managed care sample was 22.5%. Logistic regression analysis showed that number of different medications used in the previous year, total costs in the previous year and hospitalization in the previous year all significantly increased the likelihood of receiving PIM. Multiple Cox regression analysis revealed that those on cumulative levels of PIM use acted significantly as a factor related to greater hospitalization rates: the adjusted HR was 1.13 (95% CI 1.07-1.19) for 1 PIM, 1.27 (95% CI 1.19-1.35) for 2 PIM, 1.35 (95% CI 1.22-1.50) for 3 PIM, and 1.63 (95% CI 1.40-1.90) for more than 3 PIM compared to no PIM use.
conclusionsThe prevalence of PIM in managed care health plans are widely found but seem to be much lower than rates of non-managed care plans. Furthermore, our study revealed a significant association with adverse outcomes in terms of hospitalizations. These findings stress the need for further development of interventions to decrease drug-related problems and manage patients with multiple chronic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.